基于小肠胆固醇转运蛋白调控脂质吸收探讨“小肠泌别清浊”的生物学内涵及在痰湿体质调体干预中的临床应用

张安琪; 王琦; 万瑾毅; 姚海强

doi:10.3969/j.issn.1006-2157.2023.10.012

您当前的位置：

首页 >

文章列表页 >

基于小肠胆固醇转运蛋白调控脂质吸收探讨“小肠泌别清浊”的生物学内涵及在痰湿体质调体干预中的临床应用

中医体质 | 更新时间：2023-11-06

- 基于小肠胆固醇转运蛋白调控脂质吸收探讨“小肠泌别清浊”的生物学内涵及在痰湿体质调体干预中的临床应用
- Discussion on the biological connotation of "small intestine separating purity from turbidity" theory and its clinical application in the intervention of the phlegm-dampness constitution from the perspective of intestinal cholesterol transporter protein regulating lipid absorption
- 北京中医药大学学报 2023年46卷第10期页码：1411-1416
- 作者机构：
  
  北京中医药大学　北京　100029
- 作者简介：
  
  张安琪，女，在读硕士生
  # 王琦，男，教授，主任医师，博士生导师，中国工程院院士，国医大师，主要研究方向：中医体质学，E-mail: wangqi710@126.com
- 基金信息：
  
  国家自然科学基金项目(81973714;82274379);中央高校基本科研业务费资助项目(2022－JYB-JBZR－009);北京中医药大学高层次人才项目(2021－XJ-KYQD－004)
- DOI：10.3969/j.issn.1006-2157.2023.10.012
  中图分类号： R259.892
- 纸质出版日期：2023-10-30，
  
  网络出版日期：2023-08-07，
  
  收稿日期：2023-04-26，
- 稿件说明：
移动端阅览
张安琪, 王琦, 万瑾毅, 等. 基于小肠胆固醇转运蛋白调控脂质吸收探讨“小肠泌别清浊”的生物学内涵及在痰湿体质调体干预中的临床应用[J]. 北京中医药大学学报, 2023,46(10):1411-1416.

ZHANG Anqi, WANG Qi, WAN Jinyi, et al. Discussion on the biological connotation of "small intestine separating purity from turbidity" theory and its clinical application in the intervention of the phlegm-dampness constitution from the perspective of intestinal cholesterol transporter protein regulating lipid absorption[J]. Journal of Beijing University of Traditional Chinese Medicine, 2023,46(10):1411-1416.
张安琪, 王琦, 万瑾毅, 等. 基于小肠胆固醇转运蛋白调控脂质吸收探讨“小肠泌别清浊”的生物学内涵及在痰湿体质调体干预中的临床应用[J]. 北京中医药大学学报, 2023,46(10):1411-1416. DOI： 10.3969/j.issn.1006-2157.2023.10.012.

ZHANG Anqi, WANG Qi, WAN Jinyi, et al. Discussion on the biological connotation of "small intestine separating purity from turbidity" theory and its clinical application in the intervention of the phlegm-dampness constitution from the perspective of intestinal cholesterol transporter protein regulating lipid absorption[J]. Journal of Beijing University of Traditional Chinese Medicine, 2023,46(10):1411-1416. DOI： 10.3969/j.issn.1006-2157.2023.10.012.

摘要

痰湿体质是肥胖、高脂血症等多种代谢性疾病的共同土壤。多数医家将机体的代谢功能归于脾脏，然而，其与小肠的关系也同样密切。“小肠泌别清浊”是对小肠吸收、消化和排泄功能的总结。本团队提出小肠功能失调是痰湿体质者发生脂代谢紊乱的重要病理因素，但其微观机制尚不清楚。“小肠泌别清浊”与胆固醇转运蛋白尼曼－匹克C1型类蛋白1 (NPC1L1)调控脂质吸收、转运有相似的学术内涵，本文拟从NPC1L1的角度为“小肠泌别清浊”理论作出新的解读，也可证实“小肠泌别清浊”与代谢紊乱的关系。益气健运汤对于痰湿体质代谢紊乱疗效确切，方中药物均具有调节NPC1L1表达的生物学效应。从NPC1L1调控脂质吸收的角度为基于“小肠泌别清浊”的中医治法提供了新的作用靶点，丰富了益气健运汤药效机制的现代科学内涵，也为痰湿体质的调体和代谢性疾病的诊疗提供新的理论依据和临床思路。

Abstract

Phlegm-dampness constitution is the common soil for a variety of metabolic diseases such as obesity and hyperlipidemia. Most physicians attribute all metabolic functions to the spleen. However

metabolism is also closely related to the small intestine. The theory of "small intestine separating purity from turbidity" summarizes functions of absorption

digestion

and excretion of water and food by the small intestine. Our team propose that small intestine dysfunction is an essential pathological factor in the development of lipid metabolism disorders in phlegm-dampness constitution individuals. However

its molecular mechanism is not clear. The theory of "small intestine separating purity from turbidity" has the same scientific connotation as the function of Niemann-Pick C1-like 1 (NPC1L1)

which regulates lipid absorption and transportation. This paper provides a new interpretation of the "small intestine separating purity from turbidity" theory from the perspective of NPC1L1. The close association between "small intestine separating purity from turbidity" and metabolic disorders is confirmed.

Yiqi Jianyun

Decoction is effective for metabolic disorders of phlegm-dampness constitution individuals

and the herbs in this formula have been found biologically effective in regulating NPC1L1 expression. Thus

NPC1L1 regulating lipid absorption provides a new target for traditional Chinese medicine treatment method based on the theory of "small intestine separating purity from turbidity"

enriching the modern scientific connotation of the medicinal mechanism of

Yiqi Jianyun

Decoction and providing a new theoretical basis and ideas for the clinical management of metabolic diseases and adjustment of phlegm-dampness constitution.

关键词

痰湿体质小肠泌别清浊尼曼－匹克C1型类蛋白1代谢紊乱益气健运汤

Keywords

phlegm-dampness constitutionsmall intestine separating purity from turbidityNiemann-Pick C1-like 1metabolic disorderYiqi Jianyun Decoction

references

孙淑娴，马嘉轶，倪诚，等. 基于“体质土壤学说”的调体防控痰湿体质相关代谢性疾病的研究思路[J]. 中华中医药杂志，2018, 33(11)：5020－5022.

张志聪. 黄帝内经素问集注[M]. 王宏利，吕凌，校注．中国中医药科技出版社，2014：33.

张元素. 脏腑标本药式 [M]//张元素医学全书．苏凤琴，柳之然，校注. 山西：山西科学技术出版社，2012：134.

张景岳. 类经[M]. 范志霞，校注．北京：中国医药科技出版社，2011：17.

王琦. 中医藏象学[M]. 北京：人民卫生出版社，1997：846－847.

王栋先，王中琳，王新陆. 血浊理论在高脂血症治疗中的应用探析[J]. 天津中医药，2020, 37(10)：1095－1099.

王新陆. 脑血辩证[M]. 北京：中国医药科技出版社，2002：95－96.

KOBAYASHI S. The Effect of Polyphenols on Hypercholesterolemia through Inhibiting the Transport and Expression of Niemann-Pick C1－Like 1[J/OL]. Int J Mol Sci, 2019, 20(19)：4939 [2022－04－24]. https://www.mdpi.com/1422-0067/20/19/4939https://www.mdpi.com/1422-0067/20/19/4939.

LUO J, YANG HY, SONG BL. Mechanisms and regulation of cholesterol homeostasis[J]. Nat Rev Mol Cell Biol, 2020, 21(4)：225－245.

DUAN LP, WANG HH, OHASHI A, et al. Role of intestinal sterol transporters Abcg5, Abcg8, and Npc1l1 in cholesterol absorption in mice: gender and age effects[J]. Am J Physiol Gastrointest Liver Physiol, 2006, 290(2)：269－276.

VAN DER VEEN JN, KRUIT JK, et al. Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1[J]. J Lipid Res, 2005, 46(3)：526－534.

TANG W, MA Y, JIA L, et al. Niemann-Pick C1－like 1 is required for an LXR agonist to raise plasma HDL cholesterol in mice[J]. Arterioscler Thromb Vasc Biol, 2008, 28(3)：448－454.

PRAMFALK C, JIANG ZY, CAI Q, et al. HNF1alpha and SREBP2 are important regulators of NPC1L1 in human liver[J]. J Lipid Res, 2010, 51(6)：1354－1362.

IWAYANAGI Y, TAKADA T, SUZUKI H. HNF4alpha is a crucial modulator of the cholesterol-dependent regulation of NPC1L1[J]. Pharm Res, 2008, 25(5)：1134－1141.

LATASA M J, GRIFFIN M J, MOON Y S, et al. Occupancy and function of the －150 sterol regulatory element and －65 E-box in nutritional regulation of the fatty acid synthase gene in living animals[J]. Mol Cell Biol, 2003, 23(16)：5896－5907.

XIA X, JUNG D, WEBB P, et al. Liver X receptor β and peroxisome proliferator-activated receptor δ regulate cholesterol transport in murine cholangiocytes[J]. Hepatology, 2012, 56(6)：2288－2296.

方沐潮，曹乐，贝伟剑. 胆固醇吸收靶点NPC1L1研究进展[J]. 药物资讯，2013, 2(2)：19－26.

王琦. 中医体质学[M]. 北京：中国医药科技出版社，1995：200－201.

MUKU GE, KUSNADI A, KUZU G, et al. Selective Ah receptor modulators attenuate NPC1L1－mediated cholesterol uptake through repression of SREBP－2 transcriptional activity[J]. Lab Invest, 2020, 100(2)：250－264.

MA YJ, LI JM, JU ZC, et al. Danning tablets alleviate high fat diet-induced obesity and fatty liver in mice via modulating SREBP pathway[J/OL]. J Ethnopharmacol, 2021, 279：114320 [2022－04－24]. https://www.sciencedirect.com/science/article/pii/S0378874121005493?via%3Dihubhttps://www.sciencedirect.com/science/article/pii/S0378874121005493?via%3Dihub.

YANG F, CHEN GX, MA MH, et al. Fatty acids modulate the expression levels of key proteins for cholesterol absorption in Caco－2 monolayer[J/OL]. Lipids Health Dis, 2018, 17(1)：32 [2022－04－24]. https://lipidworld.biomedcentral.com/articles/10.1186/s12944-018-0675-yhttps://lipidworld.biomedcentral.com/articles/10.1186/s12944-018-0675-y.

STANCU CS, SANDA GM, DELEANU M, et al. Probiotics determine hypolipidemic and antioxidant effects in hyperlipidemic hamsters[J]. Mol Nutr Food Res, 2014, 58(3)：559－568.

LABONTÉ ED, CAMAROTA LM, ROJAS JC, et al. Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and NPC1L1－/－ mice[J]. Am J Physiol Gastrointest Liver Physiol, 2008, 295(4)：776－783.

钟春燕. 菌群及巨噬细胞脂质分解在血脂调节中的作用与机制[D]. 重庆：第三军医大学，2016.

GUO W, ZHANG Z, LI L, et al. Gut microbiota induces DNA methylation via SCFAs predisposing obesity-prone individuals to diabetes[J/OL]. Pharmacological Research, 2022, 182：106355 [2022－04－24]. https://linkinghub.elsevier.com/retrieve/pii/S1043-6618(22)00300-0https://linkinghub.elsevier.com/retrieve/pii/S1043-6618(22)00300-0.

WAN XZ, LI TT, LIU D, et al. Effect of Marine Microalga Chlorella pyrenoidosa Ethanol Extract on Lipid Metabolism and Gut Microbiota Composition in High-Fat Diet-Fed Rats[J/OL]. Mar Drugs, 2018, 16(12)：498 [2022－04－24]. https://www.mdpi.com/1660-3397/16/12/498https://www.mdpi.com/1660-3397/16/12/498.

HUANG Y, WANG JF, CHENG Y, et al. The hypocholesterolaemic effects of Lactobacillus acidophilus American type culture collection 4356 in rats are mediated by the down-regulation of Niemann－Pick C1－like 1[J]. Br J Nutr，2010, 104(6)：807－812.

李杲. 脾胃论[M].蕲国印，校注. 北京：中国中医药出版社，2019：53.

张安玲，丁元庆. 论卫气失常是肥胖的核心病机[J]. 山东中医药大学学报，2016, 40(5)：428－429.

涂蔚生. 推拿抉微[M]. 上海：上海千顷堂书局，1928：57.

周遵明，谭梅傲，彭冲，等. 黄芪葛根汤对高脂血症大鼠的降血脂作用机制研究[J]. 中药新药与临床药理，2021, 32(7)：945－951.

吴莉，舒青龙，刘玉琼，等. 黄芪多糖和炙黄芪多糖调节大鼠肠道菌群组成与多样性的比较研究[J]. 中药药理与临床，2021, 37(4)：40－47.

REPA JJ, BERGE KE, POMAJZL C, et al. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta[J]. J Biol Chem, 2002, 277(21)：18793－18800.

许瀚元. 荷叶碱在预防肥胖和减肥中的作用及其机制的研究[D]. 北京：北京协和医学院，2022.

翟意，潘晓叶，吴颢昕. 泽泻饮通过调节ApoE－/－小鼠胆固醇代谢改善动脉粥样硬化[J]. 南京中医药大学学报，2020, 36(4)：472－477.

刘垒，刘声远. 复方茯苓制剂对大鼠前脂肪细胞增殖分化以及过氧化物酶体增生物激活受体γ mRNA表达的影响[J]. 中国病理生理杂志，2005，21(7)：1364－1367.

赵嫒嫒，王连志. 浅析葛根芩连汤化裁改善小肠泌别清浊功能对血脂调节的影响[J]. 中国民间疗法，2022, 30(4)：15－16.

王琦. 王琦治疗62种疑难病[M]. 张惠敏，整理. 北京：中国中医药出版社，2012：164.

ZHAO SP, WU ZS, CHEN Y, et al. Protective effect of Hua Tan Qu Shi decoction against liver injury in rats with nonalcoholic fatty liver disease[J]. Biomed Pharmacother, 2017, 91：181－190.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

基于“脾主为卫”探讨肠道黏膜免疫在痰湿体质调体干预中的作用机制及临床应用

基于中医体质学“体病相关”理论探究痰湿体质与哮喘的相关性

痰湿体质知识图谱构建研究初探

从肠道屏障功能受损探讨痰湿体质脾失健运的微观机制